HomeCTNM • NASDAQ
add
Contineum Therapeutics Inc
Previous close
$11.74
Day range
$11.74 - $12.41
Year range
$3.35 - $15.25
Market cap
447.85M USD
Avg Volume
245.08K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 14.93M | 15.09% |
Net income | -12.79M | -24.59% |
Net profit margin | — | — |
Earnings per share | -0.45 | -12.50% |
EBITDA | -14.85M | -15.02% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 182.41M | -14.73% |
Total assets | 190.85M | -11.66% |
Total liabilities | 10.38M | 78.73% |
Total equity | 180.47M | — |
Shares outstanding | 29.18M | — |
Price to book | 1.90 | — |
Return on assets | -19.98% | — |
Return on capital | -20.56% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -12.79M | -24.59% |
Cash from operations | -12.20M | -97.71% |
Cash from investing | 14.94M | 149.50% |
Cash from financing | 19.10M | 146,861.54% |
Net change in cash | 21.85M | 160.13% |
Free cash flow | -8.81M | -154.41% |
About
Founded
2009
Website
Employees
41
